Exhibit 99.1 CLEARMIND MEDICINE INC. Condensed Interim Consolidated Financial Statements For The Three and Six Months Ended April 30, 2023 (Expressed in United States Dollars) (Unaudited) CLEARMIND MEDICINE INC. Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) (Unaudited) April 30, October 31, 2023 2022 Assets Current assets Cash and cash equivalents $5,245,707$ 128,777 Other receivables 109,625 50,933 Short-term investment (Note 3) 135,001 193,750 Prepa ...